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Abstract 
In the latest articles which were published during 2013-2014, Trichomonas vaginalis (T. vaginalis) was 
mentioned as a neglected sexual transmission disease (STD), while the exact mechanism of its pathogenesis has 
not been cleared yet. Although trichomonasiasis is easy curable, there is concern that resistance to drug are 
increasing. This common infection as concerning the important public health implications needs more research 
to be done for understanding the diagnosis, treatment, immunology and pathogenesis. In this review we 
searched all valuable and relevant information considering the pathogenesis of T. vaginalis. We referred to the 
information databases of Medline, PubMed, Scopus and Google scholar. The used keywords were the 
combinations of T. vaginalis and words associated with pathogenicity. This review discusses the host-parasite 
interaction and pathogenicity of this parasite. 
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One of the most common neglected sexually 
transmitted disease worldwide is trichomoniasis, 
which Trichomonas vaginalis (T. vaginalis), a 
flagellated protozoan parasite, is the causative agent 
but still many of pathogenicity mechanisms are 
unclear
1,2
. Trichomonas vaginalis is one of the 
human urogenital-vaginal tract parasites, which is 
more common in women rather than men
3
. T. 
vaginalis is typically pyriform shape parasite, 
although amoeboid shapes are evident in adhering 
stage to vaginal tissue in vivo
4
. Non-dividing parasite 
has four anterior flagella and the size is about 7-9µm. 
Furthermore, the parasite has undulating membrane; 
one recurrent flagellum and the costa originate in the 
kinetosomal complex
5,6
. The only natural host of this 
parasite is humans
7,8
. This infection accounts for 
almost half of all curable infections worldwide
9
. 
Trichomoniasis is frequently seen concomitantly with 
other sexual transmission diseases (STDs) such as 
gonorrhea
10
. The majority of women also have 
bacterial vaginosis with trichomoniasis
11-13
.  
Trichomoniasis has wide range of symptom from 
asymptomatic infection to severe vaginitis, which is 
show, a complicated relation between parasite and 
host
14
. Symptomatic form of the disease is seen more 
in women rather than men. One of the reasons that led 
to researchers focused more on this disease during 
decade is to proof the patient with trichomoniasis have 
more risk for human immunodeficiency virus HIV 
infection and cervical cancer
15
. All clinical isolates of 
T. vaginalis appear to be capable of infection and 
disease production
16
. This review discusses the host-
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parasite interaction, pathogenicity and vaccination of 
this parasite infection. 
 
Methodology and search 
strategy 
We searched all relevant information considering the 
association between T. vaginalis and pathogenesis. 
We referred to the information databases of Medline, 
PubMed, Scopus and Google scholar and the used 
keywords were the combinations of T. vaginalis and 
pathogenesis. 
Pathogenesis Factors 
Although T. vaginalis is the most common STD 
parasite, its pathogenesis aspects are not fully 
understood. New research on the early events of 
infection is localized
17
. Trichomonas lives on the 
surface of epithelial cells in urinary tract and this 
environment provides a parasite of nutrients needed .
The researchers gave different results in the two 
areas of work: the microscopic studies and 
biomedical analysis to obtain the behaviors and 
interactions between host and parasite
18-21
. Studies on 
the pathogenicity of this parasite have two 
perspectives: Contact dependent and non-contact 
dependent. But many common factors between these 
two views are presented. Contact-dependent 
mechanisms include adherence and adhesions, 
hemolysis, enzymatic secretion and interaction with 
the vaginal Flora. Mechanisms of non-contact 
hemolysis and proteinases addition; Cell detaching 
factor (CDF), which is perhaps one of the most 
crucial factors related to contact dependent
22-24
. 
Adhesion and Adhesions 
Adhesion of T. vaginalis to the host cell is the first 
and critical step in the pathogenesis of 
trichomoniasis
25-28
 . The tendency of the adhesion of 
Trichomonas vaginal epithelial cell lines is more 
than other cell type, which is largely dependent on 
pH, time and temperature. However higher pH and 
lower the pH of the parasite's survival is larger and 
has little mobility
29
. The interesting thing about this 
flagellate creates pseudopodia, which enhances 
adhesion to the surface. Amoeboid form deformation 
starts early signal for the attachment it also increases 
the expression of adhesion molecules
30
. Proteins and 
glycoproteins, which are involved in the mechanism of 
adhesion, include: Adhesins, laminin binding protein, 
fibronectin receptors and surface saccharides
31
. The 
surface of the trichomonad cell provides ligand-
receptor binding sites by a mosaic of adhesins. 
Parasite adhesion mediated by four adhesion proteins 
includes AP65, AP51, AP33 and AP23
32-34
. 
AP65 by at least three genes in the multiple genes is 
encoded which is similar to the malic enzyme 
encoding genes
35
. Trichomonas is a molecular mimic 
of host cell adhesion process in place that is similar to 
the gene encoding Succinyle coenzyme synthetize, by 
rest of adhesions. Thus, antigenic mimicry to adhesion 
in Trichomonas vaginalis can understand one of the 
mechanisms of escape
36
. These four adhesions 
molecule expression are regulated by iron
37,38
. 
It was observed that opposite side of the Trichomonas 
vaginalis undulating membrane binds to epithelial cell.  
Also in this area are more microfilament focused
25, 39
.  
The next molecules involved in adhesion laminin-
binding proteins are located across Trichomonas. 
Lamin is a glycoprotein that thought to play an 
important role in formation, differentiation, mobility 
and increase adhesion ability. The increased adhesion 
to the basement membrane, which leads to better 




Another molecule, which has function in adhesion in 
T. vaginalis, is extracellular matrix adhesion 
glycoprotein ‘Fibronectin’ which probably was used in 
both adhesion and nutrient acquisition  .The last 
molecules, which seem to collaborate in adhesion, are 




Here it should be noted that the adhesive molecules 
which mentioned above have not associated with the 
virulence of the parasite, while the virulent strains 
isolated from patients with symptom showed wide 
differences in their adhesion. This is indicative of the 
complex relationship between host and parasite
47
. 
At the end, it  should be mentioned that the knowledge 
about the host cell receptors which parasite adhesion 
molecules bind is little, however there is some 
evidence that laminin may be a target for trichomonad 
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Since Trichomnas vaginalis is not able to synthesize 
iron and fatty acid for their survival individually, so 
it seems that RBC is one of the main sources
49
. 
Evidences suggested that perforin like protein may 
be involved. Perforin like protein is kind of CP, 
which help to parasite for RBC hemolysis  . It has 
been observed that CP inhibitors greatly reduce RBC 
lysis. But in addition, phagocytosis in another way, 
which help to parasite to lysis RBC. It seems that 
hemolytic activity of parasite has correlation with 
virulence.  
In summary, the phenomenon of hemolysis begins by 
ligand receptor relationship and by using Perforin 
like Protein, perforated RBC wall and finally 




Next mechanism is enzymatic secretions which CP 
activities have an important role in the pathogenesis 
of parasite. CPs have a role in nutrition, hemolysis 
and also help to parasite invasion.  
Trichomonas vaginalis has 11-23 different CP 
activities that this enzyme has main role in parasite 
pathogenicity and hemolysis. In addition, CP involve 
as a lytic agent in RBC hemolysis
53-62
.  
In a study which has done on CP4, gene encoding 
CP4 protein was cloned and expressed. In this study 
it has been found that antibody against CP4 prevents 
hemolysis of erythrocyte. This is the confirmation 
about key role of CP4 in RBC lysis
63
. Another CP is 




 Next factor is T. vaginalis macrophage migration 
inhibitory factor (TvMIF), which is kind of 
proinflammatory cytokine, approximately 50% 
similar to human migration inhibitory factor 
(HuMIF). The evidences show that this factor is 
increased in prostate cancer and HuMIF play key role 
in the initiation and progression of cancer
64
.  
In addition, CPs in T. vaginalis have the ability to 
decrease vaginal immunoglobulin G and A which 




These proteins of T. vaginalis and in vivo experiments 
have presented that these proteins are immunogenic 
and could be candidate as vaccine or diagnostic tests. 
Contact-independent mechanis-
ms of pathogenicity 
Contact-independent mechanisms which are also 
involved in pathogenesis mainly related to cell free 
filtrates (Cell Detaching Factor) which released by T. 
vaginalis itself since Pentatrichomonas hominis, a 
nonpathogenic species doesn’t have CDF activity
67,68
. 
It has been reported that CDF which has a cytopathic 
effects in cell culture
24,69
. CDF is a kind of 
glycoprotein and extracellular factor which was found 
to be a 200 kDa. It seems that the level of CDF 
probably has relationship with virulence of this 
disease . It also, local antibody in vaginal environment 
which produce by B-Cell is reduced the effect of CDF. 
In addition, for example hemolysis and cytotoxicity 
mechanisms cannot be explained by contact dependent 
individually, while these effects can be seen in the 
absence of cell to cell contact
70, 71
. 
Interaction with the vaginal 
flora  
Another important issue in the pathogenicity can be 
mentioned, is interaction between T. vaginalis and the 
vaginal flora. As previously mentioned, normal 
vaginal pH is acidic while the optimum pH for this 
organism is around 5-6
72
. 
Trichomonas vaginalis for restoring in vagina should 
be passing and overcoming vaginal cell natural barrier. 
One of the most important factors is the presence of 
lactobacilli. Phukan et al, has reported that lactobacilli 
caused inhibition of T. vaginalis adhesion with varying 
degrees. So T. vaginalis overcomes flora bacterial in 
the vagina by following methods
73
.  
It has been observed that T. vaginalis phagocytes 
bacteria, and it may accurse for lactobacilli too. 
Another way is cell free filtrates (CDF) or proteins, 




Immune System Evasion 
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The ability of parasite to evade the host immune 
system is one of important aspect of pathogenesis
75
.  
Location is the first strategic tactics in T. vaginalis to 
evade the immune system which is deficient in 
complement. Surprisingly cervical mucus is deficient 
in complement which is allowed to parasite to evade 
complement-mediated destruction. The existing low 
level of complement is disappeared by the parasite's 
protease secretion
76,77
  .  
Consequence of increasing the level of Iron are CP 
increasing and RBS lysis so environment's iron 




Another evasion way is phenotypic variation 
mechanism which detect by expression or non-
expression of 270kDa protein. T. vaginalis are 
described as positive or negative P270. T. vaginalis 
which is positive cannot express protein hence 
doesn’t have the ability of adhesion
79
. 
Trichomoniasis in men 
The prevalence of this disease in male are less than 
female and most of the time appears asymptomatic, 
but it has been reported as an important Couse of 
non-gonococcal urethritis.  In half of the men 




There is a little information of its significant in male 
uro-genital tract but new researches also show a 
related of trichomniasis and prostate cancer
84-86
. 
In Seo study shows that T. vaginalis may increase IL-
1β expression in human prostate epithelium through 
activation of ROS, ERK, and NF-kB, and this in turn 
may induce the migration of monocytes and 
neutrophils and lead to an inflammatory response, 
This research was confirmed inflammatory reaction 




Trichomoniasis is not merely a nuisance disease of 
women. It is an unpleasant, irritating, and potentially 
dangerous disease that can go undiagnosed for years 
and is often passed on by an asymptomatic carrier. It 
is the world’s most common nonviral STD, and it is 
strongly associated with several complications in 
pregnancy and with an increase in the transmission of 
HIV. 
T. vaginalis is a very complex organism, from its 
biochemistry to the mechanisms of pathogenesis. 
Areas of pathogenesis that should be pursued include 
defining soluble factors, further elucidating the 
contact-dependent relationship between the vaginal 
epithelium and T. vaginalis, and defining how the 
organism can establish itself in a normally 
inhospitable and changing environment. It will also be 
important to further define the role of the human 
immune system in trichomoniasis in order to develop 
targeted intervention strategies. With continued 
collaboration and cooperation within the scientific 
community, we may one day understand the 
pathogenesis of T. vaginalis well enough to develop a 
safe, effective, and cost-effective vaccine. 
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